Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > NOX update

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Sep 27, 2013 9:20am

107 Views

Post# 21772454

RE:RE:RE:NOX update

Sallgewd, you sound like a very logical and rational person. Disregard John's posts. Whoever he is, his posts have no credibility based on their content. I learned to ignore individual forecasts and predictions long ago. Just disregard. Keep holding for your reasons and don't worry about fairy-tale predictions from others. Again, no credibility at all when they say things like that.

John, my words might seem harsh, however you need to stop making these silly predictions. You know no more than I or anyone else here. Let's stop wasting time trying to forecast share prices, especially day to day. No more of these posts please.

- MM

<< Previous

Bullboard Posts

Next >>

This battery metals stock is on a path to the global stage